{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:53Z","timestamp":1791275813227,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T00:00:00Z","timestamp":1203552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T00:00:00Z","timestamp":1203552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/jp.2008.6","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T09:29:20Z","timestamp":1203586160000},"page":"324-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population"],"prefix":"10.1038","volume":"28","author":[{"given":"S W","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Krewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nimrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Olatunbosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,21]]},"reference":[{"key":"BFjp20086_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4065\/79.7.899","volume":"79","author":"SV Rajkumar","year":"2004","unstructured":"Rajkumar SV . Thalidomide: tragic past and promising future. Mayo Clin Proc 2004; 79: 899\u2013903.","journal-title":"Mayo Clin Proc"},{"key":"BFjp20086_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/jwh.2005.14.104","volume":"14","author":"CT Lagoy","year":"2005","unstructured":"Lagoy CT, Joshi N, Cragan JD, Rasmussen SA . Use during pregnancy and lactation: an urgent call for public health action. J Womens Health 2005; 14: 104\u2013109.","journal-title":"J Womens Health"},{"key":"BFjp20086_CR3","first-page":"3921","volume":"71","author":"Food and Drug Administration","year":"2006","unstructured":"Food and Drug Administration. Requirements on content and format of labeling for human prescription drug and biological products. Fed Regist 2006; 71: 3921\u20133997.","journal-title":"Fed Regist"},{"key":"BFjp20086_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","volume":"194","author":"SW Wen","year":"2006","unstructured":"Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194: 961\u2013966.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp20086_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","volume":"45","author":"M Von Korff","year":"1992","unstructured":"Von Korff M, Wagner EH, Saunders K . A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45: 197\u2013203.","journal-title":"J Clin Epidemiol"},{"key":"BFjp20086_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/pds.1241","volume":"15","author":"E Lee","year":"2006","unstructured":"Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 2006; 15: 537\u2013545.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BFjp20086_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","volume":"191","author":"SE Andrade","year":"2004","unstructured":"Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191: 398\u2013407.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp20086_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/pds.1235","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006; 15: 546\u2013554.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BFjp20086_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-3016.2003.00542.x","volume":"18","author":"WO Cooper","year":"2004","unstructured":"Cooper WO, Hickson GB, Ray WA . Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol 2004; 18: 106\u2013111.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"BFjp20086_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2165\/00002018-200427120-00006","volume":"27","author":"H Malm","year":"2004","unstructured":"Malm H, Martikainen J, Klaukka T, Neuvonen P . Prescription of hazardous drugs during pregnancy. Drug Saf 2004; 27: 899\u2013908.","journal-title":"Drug Saf"},{"key":"BFjp20086_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","volume":"356","author":"I Lacroix","year":"2000","unstructured":"Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL . Prescription of drugs during pregnancy in France. Lancet 2000; 356: 1735\u20131736.","journal-title":"Lancet"},{"key":"BFjp20086_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1471-0528.2006.00927.x","volume":"113","author":"MK Bakker","year":"2006","unstructured":"Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, De Jong-Van Den Berg LT . Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006; 113: 559\u2013568.","journal-title":"BJOG"},{"key":"BFjp20086_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/jwh.2005.14.401","volume":"14","author":"EH Riley","year":"2005","unstructured":"Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M et al. Correlates of prescription drug use during pregnancy. J Womens Health 2005; 14: 401\u2013409.","journal-title":"J Womens Health"},{"key":"BFjp20086_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/pds.1269","volume":"15","author":"JR Hardy","year":"2006","unstructured":"Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB . Safety of medications prescribed before and during early pregnancy in a cohort of 81975 mothers from the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006; 15: 555\u2013564.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BFjp20086_CR15","first-page":"686","volume":"78","author":"C Olesen","year":"1999","unstructured":"Olesen C, Sprensen HT, de Jong-van-den Berg L, Olsen J, Steffensen FH . Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The GuromaysEuromap Group. Acta Obstet Gynecol Scand 1999; 78: 686\u2013692.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BFjp20086_CR16","first-page":"9","volume":"17","author":"D Garriguet","year":"2006","unstructured":"Garriguet D . Medication use among pregnant women. Health Rep 2006; 17: 9\u201318.","journal-title":"Health Rep"},{"key":"BFjp20086_CR17","volume-title":"Patterns of Health Care in Ontario. The ICES Practice Atlas","author":"JI Williams","year":"1996","unstructured":"Williams JI, Young W . A summary on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, Blackstien-Hirsch P, Fooks C, Naylor CD (eds). Patterns of Health Care in Ontario. The ICES Practice Atlas, 2nd edn. Canadian Medical Association: Ottawa, 1996."},{"key":"BFjp20086_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2105\/AJPH.84.3.405","volume":"84","author":"LA Schieve","year":"1994","unstructured":"Schieve LA, Handler A, Hershow R, Persky V, Davis F . Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health 1994; 84: 405\u2013410.","journal-title":"Am J Public Health"},{"key":"BFjp20086_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archinte.163.4.402","volume":"163","author":"PA Masters","year":"2003","unstructured":"Masters PA, O'Bryan TA, Zurlo J, Miller D, Joshi N . Trimethoprim\u2013sulfamethoxazole revisited. Arch Intern Med 2003; 163: 402\u2013410.","journal-title":"Arch Intern Med"},{"key":"BFjp20086_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1701-2163(16)30658-2","volume":"26","author":"SW Wen","year":"2004","unstructured":"Wen SW, Walker M . Risk of fetal exposure to folic acid antagonists. J Obstet Gynaecol Can 2004; 26: 475\u2013480.","journal-title":"J Obstet Gynaecol Can"},{"key":"BFjp20086_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","volume":"343","author":"S Hern\u00e1ndez-D\u00edaz","year":"2000","unstructured":"Hern\u00e1ndez-D\u00edaz S, Werler MM, Walker AM, Mitchell AA . Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608\u20131614.","journal-title":"N Engl J Med"},{"key":"BFjp20086_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1047-2797(00)00077-6","volume":"11","author":"SW Wen","year":"2001","unstructured":"Wen SW, Demissie KW, Liu S . Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann Epidemiol 2001; 11: 7\u201312.","journal-title":"Ann Epidemiol"},{"key":"BFjp20086_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1164\/ajrccm.158.4.9802053","volume":"158","author":"K Demissie","year":"1998","unstructured":"Demissie K, Breckenridge MB, Rhoads GG . Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998; 158: 1091\u20131095.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp20086_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00228-006-0259-z","volume":"63","author":"B K\u00e4ll\u00e9n","year":"2007","unstructured":"K\u00e4ll\u00e9n B, Otterblad Olausson P . Use of anti-asthmatic drugs during pregnancy 3. Congenital malformations in the infants. Eur J Clin Pharmacol 2007; 63: 383\u2013388.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFjp20086_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2307\/2991522","volume":"30","author":"SK Henshaw","year":"1998","unstructured":"Henshaw SK . Unintended pregnancy in the United States. Fam Plan Perspect 1998; 30: 24\u201329, 46.","journal-title":"Fam Plan Perspect"},{"key":"BFjp20086_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.contraception.2004.01.012","volume":"70","author":"DG Foster","year":"2004","unstructured":"Foster DG, Bley J, Mikanda J, Induni M, Arons A, Baumrind N et al. Contraceptive use and risk of unintended pregnancy in California. Contraception 2004; 70: 31\u201339.","journal-title":"Contraception"},{"key":"BFjp20086_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2307\/2991642","volume":"31","author":"DA Glei","year":"1999","unstructured":"Glei DA . Measuring contraceptive use patterns among teenage and adult women. Fam Plan Perspect 1999; 31: 73\u201380.","journal-title":"Fam Plan Perspect"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp20086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp20086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp20086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:53:48Z","timestamp":1647608028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp20086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,21]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BFjp20086"],"URL":"https:\/\/doi.org\/10.1038\/jp.2008.6","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,21]]},"assertion":[{"value":"9 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}